Phibro Animal Health PAHC
NASDAQ PAHC
$35.02 -0.95 (-2.64%)
At close: Nov 16, 2026 · 4:00 PM EST

Phibro Animal Health (PAHC) Return on Capital Employed [ROCE] (2014 - 2026)

Updated

Phibro Animal Health (PAHC) posted Return on Capital Employed [ROCE] of 15.90% for fiscal Q1 2027 (quarter ended Sep 30, 2026), up 2.85 percentage points from 13.06% a year earlier but down 0.90 percentage points from the prior quarter.

Analysis

Phibro Animal Health (PAHC) Return on Capital Employed [ROCE] (2014 - 2026) Analysis & Trends

For FY2026 (ended Jun 30, 2026), Phibro Animal Health's Return on Capital Employed [ROCE] came in at 17.44%, up 4.86 percentage points from FY2025.

  • Annual Return on Capital Employed [ROCE] shows a five-year change of +5.90 percentage points (FY2021 to FY2026).
  • In prior fiscal years, Phibro Animal Health's Return on Capital Employed [ROCE] was 12.58% in FY2025 (+5.68 pp), 6.90% in FY2024 (-2.36 pp), 9.26% in FY2023 (-2.09 pp) and 11.35% in FY2022 (-0.19 pp).
  • Quarterly Return on Capital Employed [ROCE] has run from a low of 6.87% in fiscal Q4 2024 to a high of 16.81% in fiscal Q4 2026 over five years.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has increased in each of the last nine quarters, with an average year-over-year change of +4.12 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was fiscal Q3 2026, with a gain of 6.54 percentage points; the weakest was fiscal Q1 2024, with a drop of 2.95 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior fiscal quarters was 16.81% (Q4 2026), 15.74% (Q3 2026) and 15.17% (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 17.52%
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 21.60%
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 4.65%
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 9.91%
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 17.37%
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn -6.15%
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 11.32%
10 Phibro Animal Health 1.42 Bn 1.11 Bn 128.54 Mn 15.90%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 15.90%
Jun 30, 2026 16.81%
Mar 31, 2026 15.74%
Dec 31, 2025 15.17%
Sep 30, 2025 13.06%
Jun 30, 2025 10.56%
Mar 31, 2025 9.20%
Dec 31, 2024 9.14%
Sep 30, 2024 9.00%
Jun 30, 2024 6.87%
Mar 31, 2024 7.46%
Dec 31, 2023 7.34%
Sep 30, 2023 7.22%
Jun 30, 2023 9.07%
Mar 31, 2023 8.89%
Dec 31, 2022 9.09%
Sep 30, 2022 10.17%
Jun 30, 2022 10.77%
Mar 31, 2022 10.82%
Dec 31, 2021 11.27%
API Access

Phibro Animal Health Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=PAHC&period=max&api_key=YOUR_API_KEY